Parkinson's patients no longer need to rely on a needle for apomorphine antidote for 'off' episodes after new FDA approval
A morphine derivative — usually injected or infused — used to treat “off” episodes in Parkinson’s is now up for grabs in a convenient under-the-tongue dissolvable formulation …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
